Tyrosinase 243-251 mutant (HLA-A*01:01) 244S

Tyrosinase 243-251 mutant (HLA-A*01:01) 244S
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP11443_1
Antigen Peptide TTyrosinase 243-251 mutant (HLA-A*01:01) 244S KSDICTDEY for stimulation of... more
Product information "Tyrosinase 243-251 mutant (HLA-A*01:01) 244S"
Antigen Peptide TTyrosinase 243-251 mutant (HLA-A*01:01) 244S KSDICTDEY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. ingle peptide (KSDICTDEY) for stimulation of human Gp 100-specific CD8+ T-cells.

 
Sequence:KSDICTDEY
Gene:Tyr
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Tyrosinase
Species:Human
Allele:HLA-A*01:01
Application :Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication :AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Molecular Weight: 1194.60
Viewed